AFTER MORE THAN 15 YEARS, with deep pride and gratitude for the relationships we’ve built, the trust we’ve earned, and the work we’ve accomplished together, Hale Advisors has decided to wind down our business operations in 2026.
It’s been a remarkable journey, made so by the extraordinary people inside our company and within the innovative pharmaceutical, biotech, and medical device industry we served.
Along the way, we helped elevate Marketing Governance into a true strategic function, supporting compliance through every major shift—from early social media to omnichannel, modular content, and now AI.
We offer our deepest thanks to our present and past clients, partners, friends, and especially the ‘Halers’ who made these 15 years successful and meaningful. May our relationships endure a lifetime.
For Questions Please Contact Zoe Dunn
